|
|
| | Propanedioic acid, ((2-amino-3-hydroxy-1-oxopropyl)amino)(2-(5-(aminom ethyl)-2,5-dihydro-4-hydroxy-2-oxo-1H-pyrrol-3-yl)-2-oxoethyl)- Basic information |
| | Propanedioic acid, ((2-amino-3-hydroxy-1-oxopropyl)amino)(2-(5-(aminom ethyl)-2,5-dihydro-4-hydroxy-2-oxo-1H-pyrrol-3-yl)-2-oxoethyl)- Chemical Properties |
| Boiling point | 934.544±65.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.706±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 1.525±0.10(predicted) |
| Toxicity | LD50 intraperitoneal in mouse: 1gm/kg |
| | Propanedioic acid, ((2-amino-3-hydroxy-1-oxopropyl)amino)(2-(5-(aminom ethyl)-2,5-dihydro-4-hydroxy-2-oxo-1H-pyrrol-3-yl)-2-oxoethyl)- Usage And Synthesis |
| Uses | Malonomicin (Antibiotic K16) is an antibiotic with anti-protozoa and anti-trypanosome activities. Malonomicin also shows anti-trypanosome activity in vivo[1][2]. | | in vivo | Malonomicin (30 mg/kg; i.p., once) eliminates the infection status of trypanosoma infected-mice and shows no harmful effects with daily dose of 50 mg/kg[2]. | Animal Model: | Mice with Trypanosoma congolense infection[2] | | Dosage: | 30 mg/kg | | Administration: | Intraperitoneal injection; 30 mg/kg, once | | Result: | Eliminated all trypanosomes from in the blood of infected mice. |
| | IC 50 | Trypanosoma | | References | [1] Emilio L. Ghisalberti. Bioactive Tetramic Acid Metabolites. Studies in Natural Products Chemistry. Volume 28, Part I, 2003, Pages 109-163. [2] Ottens Hendrik and Vos Cornelis. Preparation of an antibiotic for the treatment of trypanosomiasis. NL6701356. 1967. |
| | Propanedioic acid, ((2-amino-3-hydroxy-1-oxopropyl)amino)(2-(5-(aminom ethyl)-2,5-dihydro-4-hydroxy-2-oxo-1H-pyrrol-3-yl)-2-oxoethyl)- Preparation Products And Raw materials |
|